Short Interest in Owens & Minor, Inc. (NYSE:OMI) Increases By 14.3%

Owens & Minor, Inc. (NYSE:OMI) saw a large growth in short interest in the month of November. As of November 29th, there was short interest totalling 9,110,000 shares, a growth of 14.3% from the November 14th total of 7,970,000 shares. Based on an average daily volume of 1,680,000 shares, the short-interest ratio is presently 5.4 days. Currently, 15.1% of the shares of the company are short sold.

NYSE:OMI opened at $6.15 on Friday. Owens & Minor has a 52 week low of $2.43 and a 52 week high of $8.43. The company has a quick ratio of 0.85, a current ratio of 1.74 and a debt-to-equity ratio of 3.57. The stock has a market capitalization of $483.96 million, a PE ratio of 5.35 and a beta of 1.43. The stock’s 50-day moving average price is $6.83 and its 200-day moving average price is $4.99.

Owens & Minor (NYSE:OMI) last posted its earnings results on Wednesday, November 6th. The company reported $0.20 EPS for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.01. Owens & Minor had a positive return on equity of 4.89% and a negative net margin of 2.88%. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.45 billion. During the same period last year, the firm earned $0.32 EPS. The company’s quarterly revenue was down 2.7% on a year-over-year basis. Sell-side analysts expect that Owens & Minor will post 0.55 earnings per share for the current fiscal year.

The firm also recently announced a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be given a dividend of $0.0025 per share. The ex-dividend date is Friday, December 13th. Owens & Minor’s dividend payout ratio (DPR) is presently 0.87%.

OMI has been the topic of a number of analyst reports. ValuEngine cut Owens & Minor from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 3rd. Bank of America raised their target price on Owens & Minor from $4.00 to $7.50 and gave the company a “neutral” rating in a research report on Friday, September 6th. Finally, Zacks Investment Research cut Owens & Minor from a “strong-buy” rating to a “hold” rating in a research report on Saturday, November 9th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $6.90.

Several large investors have recently bought and sold shares of the company. Metropolitan Life Insurance Co NY acquired a new stake in shares of Owens & Minor during the 3rd quarter valued at about $129,000. Voloridge Investment Management LLC acquired a new stake in Owens & Minor in the 3rd quarter worth about $330,000. Public Employees Retirement System of Ohio acquired a new stake in Owens & Minor in the 3rd quarter worth about $424,000. Point72 Asset Management L.P. acquired a new stake in Owens & Minor in the 3rd quarter worth about $1,332,000. Finally, State Street Corp boosted its holdings in Owens & Minor by 2.9% in the 3rd quarter. State Street Corp now owns 2,248,255 shares of the company’s stock worth $13,062,000 after buying an additional 64,087 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More: Dogs of the Dow

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with's FREE daily email newsletter.